Viveca Nerme

Title: Viveca Nerme: Innovator in Pharmaceutical Formulations

Introduction

Viveca Nerme is a prominent inventor based in Vastra Frolunda, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that target specific medical conditions. Her innovative work has led to the creation of a patent that addresses critical health issues.

Latest Patents

Viveca Nerme holds a patent for "Formulations comprising an inhibitor of carboxypeptidase U and a thrombin inhibitor." This invention relates to pharmaceutical formulations that combine an inhibitor of carboxypeptidase U (CPU) and a thrombin inhibitor with a pharmaceutically acceptable adjuvant, diluent, or carrier. The formulations are designed for the treatment of conditions where inhibition of CPU and/or thrombin is required or desired.

Career Highlights

Viveca has established herself as a key figure in the pharmaceutical industry. She works at AstraZeneca AB, a leading global biopharmaceutical company. Her expertise in pharmaceutical formulations has been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Throughout her career, Viveca has collaborated with notable colleagues, including Tommy Abrahamsson and Magnus Polla. These partnerships have fostered innovation and contributed to the success of her projects.

Conclusion

Viveca Nerme's contributions to pharmaceutical formulations exemplify her dedication to improving healthcare through innovation. Her patent and work at AstraZeneca AB highlight her role as a significant inventor in the industry.